Mpox Cases Thailand Spike with New Variant Detection

Friday, 23 August 2024, 04:10

Mpox cases in Thailand have escalated with the confirmation of the first dangerous variant in Asia. This significant outbreak reaffirms the need for preparedness and response.

Independent — Mpox Cases Thailand Spike with New Variant Detection

Mpox Cases Thailand: A Growing Concern

Mpox cases in Thailand have taken a concerning turn as authorities confirm the emergence of a new variant. This situation highlights the urgency for global health organizations and local governments to mobilize resources effectively.

Bavarian Nordic's Vaccine Production Plans

Danish biotech firm Bavarian Nordic might increase its production of the mpox vaccine even before receiving specific orders. CEO Paul Chaplin elaborated on the critical need for the company to assess production capacity amidst ongoing discussions with the World Health Organization.

Urgency in vaccine production
Potential for 10 million doses by 2025
Current capacity limited to 2 million doses this year

The discussions with international partners, including Gavi and Africa CDC, aim to accelerate mpox vaccine availability. As each week passes without switching manufacturing focus, potential capacity is lost.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.